←
gary taubes5,142 posts
gary taubes avatar

gary taubes

@garytaubes

Author of Rethinking Diabetes, The Case for Keto, The Case Against Sugar, Why We Get Fat, Good Calories, Bad Calories, Bad Science, and Nobel Dreams

◷ Joined June 2009▧ 617 Photos and videos
gary taubes avatar
gary taubes@garytaubes·1 Jan 2024

1960: < 2 million Americans with diagnosed diabetes Today: 30 million* Is this a problem that can be solved by drug therapy? There must be a better way My new book, Rethinking Diabetes, is out Jan 2 tinyurl.com/5ft2btcy #diabetes #wefightdiabetes * cdc.gov/diabetes/data/statis… @diabetesdaily @ADA_DiabetesPro @IntDiabetesFed @JoslinDiabetes @diaTribeNews @Diabetescouk @BeyondType1 @DiabetesCanada @ADCESdiabetes @Diabetes_DRI @martymakary @samiinkinen @bretschermd @davidludwig @lowcarbgp @robbwolf @drjasonfung @KenDBerryMD @SBakerMD @drmarkhyman @shellenberger @DrJBhattacharya

Post attachment
gary taubes avatar
gary taubes@garytaubes·Nov 15

In 1942, Louis Newburgh explained weight gain with menopause as the result of bonbons at bridge parties. His paper established the central dogma of obesity science. Research from the 1980s on what sex hormones actually do to fat cells tells a different story. My new Substack post: Sex, Fat and Aging? uncertaintyprinciples.substa…

Post attachment
gary taubes avatar
gary taubes@garytaubes·Nov 14

I pointed this out in the epilogue of Good Calories, Bad Calories in 2007: if the then-ongoing $200 million LookAHEAD trial had included a low-carb diet arm, we might have resolved the controversy with that trial. Instead, LookAHEAD was ended "for futility," as they say in the clinical trial business, and we're still hoping (@DrJBhattacharya) someone will step up and fund an RCT with hard endpoints that could settle this.

Just imagine if this diet had been included for study in the (failed) Women's Health Initiative, the (failed) Sydney Diet Heart Study, the (failed) Minesotta Coronary Experiment, the (failed) Look AHEAD trial etc etc including the other studies reviewed by @garytaubes, @bigfatsurprise and @zoeharcombe amongst others. The diet-heart debate would have been resolved already in 2-3 decades ago.

gary taubes avatar
gary taubes@garytaubes·Nov 14

That it's not an RCT but a retrospective study is a critical caveat here. Another is the lack of balance between the two comparisons: one getting the telemedicine intervention, the other only usual care. On the other hand, as @bschermd says,this is better evidence than what critics of carb restriction use to argue that it's harmful.

Most doctors believe keto diets or ketogenic therapy means elevated cardiovascular risk. A new study in Cardiology and Therapy looked at that assumption in nearly 10,000 patients. And guess what? They found the exact opposite! 🧵

Post attachment
gary taubes avatar
gary taubes@garytaubes·Nov 12

As it says below, "I gave. Will you?"

People with type 2 diabetes do not have to "live with it." The @OfficialADSOrg exists to teach that. Type 2 can go into remission with food and lifestyle. You don't have to manage it forever with more and more medication. In 2021, the American Diabetes Association itself convened the expert group that defined remission: an A1C under 6.5% for at least 3 months after the usual diabetes drugs are stopped. That report is in ADA's own journal, Diabetes Care. Type 2 is not a life sentence. If you have type 2, start here: americandiabetessociety.org Introducing the American Diabetes Society [Diabetes Truth] 2026 youtube.com/watch?v=tPX_dvZD… Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes. Diabetes Care 2021: ncbi.nlm.nih.gov/pmc/article…

Post attachment
gary taubes avatar
gary taubes@garytaubes·Nov 2

Food is Medicine isn't just a new book by Dariush Mozaffarian; it's a dominant theme in modern nutrition policy: chronic disease comes less from eating bad food than from not eating enough good food. So telling folks to avoid sugar and white bread is always a good idea, but not as good as getting them to eat broccoli, salmon, and quinoa. It sounds reasonable. But if food is medicine, it has to be tested like medicine. When it is, the results are thin, and a ketogenic diet keeps winning. Is Food Really Medicine? (If So, Which Foods?) uncertaintyprinciples.substa…

Post attachment
Dr. David Ludwig avatar
⟳ gary taubes retweeted
Dr. David Ludwig@davidludwigmd·Oct 27

Is high LDL cholesterol (or apoB) harmful ONLY with poor metabolic health, characterized by low HDLc? New study from preeminent lipidologist Sniderman: "when HDL-C is high ... effect of changing apoB vanishes" PS: A low-carb diet potently increases HDLc academic.oup.com/eurjpc/adva…

Post attachment
gary taubes avatar
gary taubes@garytaubes·Oct 18

Here are 2 ways to think of ketogenic and carnivore diets: 1. Potent therapies for a range of chronic diseases—from obesity and diabetes to schizophrenia and bi-polar depressive disorder. As @Hubermanlab says in his new book Protocols, the benefits can be “remarkable.” 2. Fascinating challenges to the conventional scientific thinking on the diet-disease relationship. Huberman and the authors of a recent Science paper on "essential" sugars in human evolution will accept the first, but actively resist even considering the second. The obvious question: where’s their curiosity? Are they so trapped in conventional thinking that they can’t even entertain the notion that there might be something new to learn here? Sugars in Evolution and Huberman’s Protocols uncertaintyprinciples.substa…

gary taubes avatar
gary taubes@garytaubes·Oct 8

From @doctortro's clinical practice, use of a therapeutic ketogenic diet resulted in a dramatic improvement in CVD risk: Using the AHA’s own PREVENT equations, estimated 10-year risk fell: 29% for ASCVD 28% for total cardiovascular disease 42% for heart failure Median weight loss was 12.2% Systolic blood pressure fell 10.7 mm HgHbA1c fell 0.48 percentage points Triglycerides fell 34 mg/dL.

Do you eat low carb and worry about your heart? The ADA recognizes lower-carb eating for people with diabetes or prediabetes. New federal guidelines say it may help some people with chronic disease. Yet the AHA puts keto in its lowest tier for diet-guideline alignment. We used its PREVENT calculator: in our paired cohort, calculated 10-year ASCVD risk fell 29% after one year. Watch what we found. Read the article: toward.health/real-food-keto…

2:03
gary taubes avatar
gary taubes@garytaubes·Oct 5

Once upon a time, not all that long ago, medical authorities thought that the best way to resolve scientific controversies was to air them out, discuss the evidence on both sides, what was known and what was not, and so establish what research was needed to settle the issue. Well, those days may be gone. Now researchers, influential authorities (and, of course, our friends the health reporters) have decided that given the opportunity to review a vitally important subject, their job is to advocate for what they believe, ignore the counterarguments and inconvenient evidence and hope for the best. In my latest Substack, I discuss three very recent examples of this advocacy phenomenon, and compare it to how scientists used to discuss controversial science, back when they were more interested in getting the right answer than establishing their authority.  Discussing Controversy in Medical Science: Air It Out or Sweep It Under the Rug? uncertaintyprinciples.substa…

Post attachment
Dr. David Ludwig avatar
⟳ gary taubes retweeted
Dr. David Ludwig@davidludwigmd·Sep 23

The Endocrine Society has a new "scientific statement" on the gaps (or rather black holes) in obesity science. @garytaubes shines cosmic light on the matter. If you don't subscribe to his Substack, this essay alone is worth the price.

Here’s a question from my latest Substack post. It's about obesity and obesity medicine and it should be rhetorical. Regrettably, it's not: Q. If you were going to study a disorder of excess fat accumulation (i.e., too much fat in fat cells) and the action of the drugs that so spectacularly treat it, wouldn’t you be at least vaguely interested in the physiological mechanisms that determine how much fat those fat cells will store? 1. Yes? 2. No? Common sense (and the history of obesity science) might suggest the answer has to be yes, but the expert authors of a recent Endocrine Society Scientific Statement on  “Obesity science, research gaps, and opportunities in the new era of obesity medicines,” would claim otherwise. They put the brain at the center of obesity science and GLP-1 action, then omit (ignore?) a century of science suggesting that since it's the fat cells that get fatter in obesity, the direct neuroendocrine regulation of fat storage in those cells must be relevant. These expert authors include @kevinhallPhD and @danielJdrucker and a half dozen others, and we can assume they know more about obesity than anyone. They’re the experts. But if so, why do they ignore the fat cell itself when discussing why we accumulate excess fat in fat cells, and why GLP-1 drugs do such a remarkable job of reversing that process? What are they missing with their conviction that obesity is an "appetitive behavior" disorder? The Black Hole at the Galactic Core of Obesity and GLP-1 Drug Science uncertaintyprinciples.substa…

Post attachment
gary taubes avatar
gary taubes@garytaubes·Sep 23

Here’s a question from my latest Substack post. It's about obesity and obesity medicine and it should be rhetorical. Regrettably, it's not: Q. If you were going to study a disorder of excess fat accumulation (i.e., too much fat in fat cells) and the action of the drugs that so spectacularly treat it, wouldn’t you be at least vaguely interested in the physiological mechanisms that determine how much fat those fat cells will store? 1. Yes? 2. No? Common sense (and the history of obesity science) might suggest the answer has to be yes, but the expert authors of a recent Endocrine Society Scientific Statement on  “Obesity science, research gaps, and opportunities in the new era of obesity medicines,” would claim otherwise. They put the brain at the center of obesity science and GLP-1 action, then omit (ignore?) a century of science suggesting that since it's the fat cells that get fatter in obesity, the direct neuroendocrine regulation of fat storage in those cells must be relevant. These expert authors include @kevinhallPhD and @danielJdrucker and a half dozen others, and we can assume they know more about obesity than anyone. They’re the experts. But if so, why do they ignore the fat cell itself when discussing why we accumulate excess fat in fat cells, and why GLP-1 drugs do such a remarkable job of reversing that process? What are they missing with their conviction that obesity is an "appetitive behavior" disorder? The Black Hole at the Galactic Core of Obesity and GLP-1 Drug Science uncertaintyprinciples.substa…

Post attachment
gary taubes avatar
gary taubes@garytaubes·Sep 6

In the past two years, 14 studies have exploited the same remarkable natural experiment: the end of sugar rationing in Britain in 1953. All have come to essentially the same conclusion: greater exposure to sugar early in life is associated with more chronic disease decades later—diabetes, heart disease, cancer, depression, dementia, and more. These studies aren’t appearing in obscure journals. They’re being published in Science, the BMJ, PNAS, the American Journal of Clinical Nutrition, Nature Communications, and elsewhere. Meanwhile, @tamarhaspel of the @washingtonpost confidently tells us in a recent column: “The real problem with sugar is simply that we like it.” So why the confidence? And what do we do with this remarkable body of new evidence? Ultimately, the question is one we’ve been arguing about for decades: Should we treat sugar as a chronic toxin—or as a benign indulgence that becomes harmful only because it provides excess calories? Is Sugar Toxic? Can It Cause Cancer? CHD? Frailty? Dementia? Read the post on Uncertainty Principles uncertaintyprinciples.substa…

Post attachment
gary taubes avatar
gary taubes@garytaubes·Sep 2

Do GLP-1 drugs work by inhibiting appetite or by prioritizing fat oxidation over storage--changing metabolic fuel partitioning, in the lingo? Most researchers (and X influencers) will insist it's the former, but they'll do so because they don't think deeply about the alternative. Maybe the new paper by Friedman & Lund will help. 🤞

Could Wegovy’s weight-lowering effect be caused by how the drug affects fuel metabolism? 1/16

Post attachment
gary taubes avatar
gary taubes@garytaubes·Aug 28

Well, this is nice to see. And from Sam Klein of all people. He was a co-author on two major Atkins studies in the 00s, but seemed to be stumbling blindly over the results. He seems to have his eyes open now. Signs of a paradigm shifting?

When we were dating, my engineer now-husband was floored that I didn’t trust Scientific American’s take on nutrition. After we were married my husband adopted Keto and lost his T2 diabetic dawn effect and fatty liver disease. On Keto, eventually his labs made him appear to be non-diabetic Now, 14 years since I first objected to nutrition à la Scientific American it looks like the magazine is finally coming around 😊 I have @garytaubes to thank for the insights in his book, Good Calories, Bad Calories, that started my low carb journey. Nicely done, Gary Taubes 🌸 @sciam scientificamerican.com/artic…